You are here

  • Home
  • Archive
  • Volume 33, Issue Suppl 4
  • PO003/#269  Ignite: a phase II signal-seeking trial of adavosertib targeting recurrent high grade serous ovarian cancer with cyclin E1 over-expression with and without gene amplification

Article metrics

Article menu

Download PDFPDF

Plenary 01: Oral Abstract Presentations
AS11. Ovarian cancer
PO003/#269  Ignite: a phase II signal-seeking trial of adavosertib targeting recurrent high grade serous ovarian cancer with cyclin E1 over-expression with and without gene amplification

 

Online download statistics by month:

Online download statistics by month: November 2023 to December 2024

AbstractFullPdf
Nov 2023148031
Dec 202398017
Jan 20247205
Feb 202483010
Mar 202481025
Apr 20247306
May 202481028
Jun 202445012
Jul 20243609
Aug 2024550181
Sep 202444014
Oct 202443011
Nov 20243904
Dec 2024601
Total9040354